1p36 deletion syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1606OMIM:616975Q93.5
Who is this for?
Show terms as
2Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

1p36 deletion syndrome (also known as monosomy 1p36 or 1p36 microdeletion syndrome) is a chromosomal disorder caused by a deletion of genetic material from the short arm (p) of chromosome 1 at band 36. It is one of the most common terminal deletion syndromes in humans. The condition affects multiple body systems and is characterized by distinctive facial features, including a flat nasal bridge, deep-set eyes, straight eyebrows, a pointed chin, and a large or late-closing anterior fontanelle. Individuals typically present with intellectual disability of varying severity, developmental delay, hypotonia (low muscle tone), and seizures, which occur in approximately half of affected individuals. The syndrome affects the neurological, cardiovascular, musculoskeletal, and sensory systems. Structural brain abnormalities may be present, and many individuals have speech and language impairment that is often more severe than their overall cognitive delay. Congenital heart defects, including cardiomyopathy (particularly dilated cardiomyopathy), patent ductus arteriosus, and other structural heart anomalies, are reported in a significant proportion of patients. Hearing loss (sensorineural or conductive) and vision problems are also common. Behavioral features may include self-injurious behavior, temper outbursts, and autistic-like features. Growth abnormalities, feeding difficulties in infancy, and short stature may also be observed. There is currently no cure for 1p36 deletion syndrome, and management is supportive and symptom-based. Treatment typically involves early intervention programs, physical therapy, occupational therapy, and speech therapy to optimize developmental outcomes. Seizures are managed with antiepileptic medications, and cardiac anomalies may require medical or surgical intervention. Regular monitoring by a multidisciplinary team including neurologists, cardiologists, audiologists, and ophthalmologists is recommended. Genetic counseling is advised for affected families to discuss recurrence risk and family planning.

Also known as:

Clinical phenotype terms— hover any for plain English:

Horizontal eyebrowHP:0011228
Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for 1p36 deletion syndrome.

View clinical trials →

No actively recruiting trials found for 1p36 deletion syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the 1p36 deletion syndrome community →

Specialists

2 foundView all specialists →
MM
Mary Norton, MD
Specialist
PI on 3 active trials
PM
Peer Dar, MD
BRONX, NY
Specialist
PI on 2 active trials

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to 1p36 deletion syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open 1p36 deletion syndromeForum →

No community posts yet. Be the first to share your experience with 1p36 deletion syndrome.

Start the conversation →

Latest news about 1p36 deletion syndrome

No recent news articles for 1p36 deletion syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about 1p36 deletion syndrome

What is 1p36 deletion syndrome?

1p36 deletion syndrome (also known as monosomy 1p36 or 1p36 microdeletion syndrome) is a chromosomal disorder caused by a deletion of genetic material from the short arm (p) of chromosome 1 at band 36. It is one of the most common terminal deletion syndromes in humans. The condition affects multiple body systems and is characterized by distinctive facial features, including a flat nasal bridge, deep-set eyes, straight eyebrows, a pointed chin, and a large or late-closing anterior fontanelle. Individuals typically present with intellectual disability of varying severity, developmental delay, hy

How is 1p36 deletion syndrome inherited?

1p36 deletion syndrome follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does 1p36 deletion syndrome typically begin?

Typical onset of 1p36 deletion syndrome is neonatal. Age of onset can vary across affected individuals.

Which specialists treat 1p36 deletion syndrome?

2 specialists and care centers treating 1p36 deletion syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.